Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shomik Sengupta

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Journal of Contemporary Brachytherapy|May 24, 2018
A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomesMichael Chao, Sandra Spencer, Mario Guerrieri, et al.
Asia-Pacific Journal of Clinical Oncology|January 29, 2026
Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case SeriesKar Ven Cavan Chow, Ciara Conduit, Sophie O'Haire, et al.
JCO Oncology Practice|June 16, 2023
Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance RecommendationsCiara Conduit, Jeremy Lewin, Andrew Weickhardt, et al.
BJUI Compass|July 22, 2025
A population-based analyses of the evolving management of cN1M0 prostate cancer in the PSMA-PET eraJennifer Ward, Kevin Armstrong, Therese Min-Jung Kang, et al.
BJU International|October 5, 2017
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cellsLaura H Porter, Kohei Hashimoto, Mitchell G Lawrence, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinomaSameer A Siddiqui, Xavier Frigola, Sandra Bonne-Annee, et al.
Frontiers in Surgery|October 21, 2022
A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyondJeffrey J Leow, Wei Shen Tan, Wei Phin Tan, et al.
BJU International|July 17, 2021
'Pain-free TRUS B': a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501)Dickon Hayne, Jeremy Grummet, David Espinoza, et al.
Journal of Patient-Reported Outcomes|March 27, 2025
Development and psychometric evaluation of a patient-reported symptom index for patients with non-muscle invasive bladder cancer: the NMIBC-SIClaudia Rutherford, Margaret-Ann Tait, Daniel S J Costa, et al.
European Urology Oncology|May 7, 2025
Early Results from the CONFIRM Trial: Utility of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate CancerJianliang Liu, Laurence Harewood, Dominic Bagguley, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Journal of Contemporary Brachytherapy|May 24, 2018
A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomesMichael Chao, Sandra Spencer, Mario Guerrieri, et al.
Asia-Pacific Journal of Clinical Oncology|January 29, 2026
Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case SeriesKar Ven Cavan Chow, Ciara Conduit, Sophie O'Haire, et al.
JCO Oncology Practice|June 16, 2023
Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance RecommendationsCiara Conduit, Jeremy Lewin, Andrew Weickhardt, et al.
BJUI Compass|July 22, 2025
A population-based analyses of the evolving management of cN1M0 prostate cancer in the PSMA-PET eraJennifer Ward, Kevin Armstrong, Therese Min-Jung Kang, et al.
BJU International|October 5, 2017
Intraductal carcinoma of the prostate can evade androgen deprivation, with emergence of castrate-tolerant cellsLaura H Porter, Kohei Hashimoto, Mitchell G Lawrence, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinomaSameer A Siddiqui, Xavier Frigola, Sandra Bonne-Annee, et al.
Frontiers in Surgery|October 21, 2022
A systematic review and meta-analysis on delaying surgery for urothelial carcinoma of bladder and upper tract urothelial carcinoma: Implications for the COVID19 pandemic and beyondJeffrey J Leow, Wei Shen Tan, Wei Phin Tan, et al.
BJU International|July 17, 2021
'Pain-free TRUS B': a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501)Dickon Hayne, Jeremy Grummet, David Espinoza, et al.
Journal of Patient-Reported Outcomes|March 27, 2025
Development and psychometric evaluation of a patient-reported symptom index for patients with non-muscle invasive bladder cancer: the NMIBC-SIClaudia Rutherford, Margaret-Ann Tait, Daniel S J Costa, et al.
European Urology Oncology|May 7, 2025
Early Results from the CONFIRM Trial: Utility of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate CancerJianliang Liu, Laurence Harewood, Dominic Bagguley, et al.
Pageof 17